Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Medicure (MCUJF) Non-Current Deffered Revenue (2016 - 2021)

Medicure has reported Non-Current Deffered Revenue over the past 8 years, most recently at $51566.8 for Q4 2021.

  • For Q4 2021, Non-Current Deffered Revenue fell 79.93% year-over-year to $51566.8; the TTM value through Dec 2021 reached $51566.8, down 79.93%, while the annual FY2021 figure was $51000.0, 80.61% down from the prior year.
  • Non-Current Deffered Revenue for Q4 2021 was $51566.8 at Medicure, down from $256963.3 in the prior quarter.
  • Over five years, Non-Current Deffered Revenue peaked at $2.3 million in Q4 2017 and troughed at $51566.8 in Q4 2021.
  • A 5-year average of $1.0 million and a median of $890818.1 in 2019 define the central range for Non-Current Deffered Revenue.
  • Biggest five-year swings in Non-Current Deffered Revenue: decreased 16.62% in 2017 and later crashed 79.93% in 2021.
  • Year by year, Non-Current Deffered Revenue stood at $2.3 million in 2017, then crashed by 32.73% to $1.5 million in 2018, then plummeted by 42.22% to $890818.1 in 2019, then plummeted by 71.15% to $256963.3 in 2020, then crashed by 79.93% to $51566.8 in 2021.
  • Business Quant data shows Non-Current Deffered Revenue for MCUJF at $51566.8 in Q4 2021, $256963.3 in Q4 2020, and $890818.1 in Q4 2019.